TrialClinical cancer research : an official journal of the American Association for Cancer Research2008

A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer.

Michael J Robertson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.